Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anisodamine (654-2) improves impaired cognitive function induced by experimental brain damage]

S Zhang1, J Liu, L He

  • 1Institute of Basic Medical Sciences, CAMS, Beijing.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|August 1, 1995
PubMed
Summary

This study shows that 654-2 improves learning and memory deficits in a rat model of dementia. The compound also offers brain cell protection against free radical damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatigue reduction by sequential stimulation of multiple motor points in a muscle.

Clinical orthopaedics and related research·1995
Same author

Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection.

Fertility and sterility·1995
Same author

Fluidity of the lipid domain of cell wall from Mycobacterium chelonae.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same author

Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Denaturant unfolding of the ferric enterobactin receptor and ligand-induced stabilization studied by site-directed spin labeling.

Biochemistry·1995
Same author

Identification of an essential cysteinyl residue in the ArsC arsenate reductase of plasmid R773.

Biochemistry·1995

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Brain injury models in rats were established using medial frontal cortex lesions or cerebral ischemia and reperfusion.
  • These models successfully induced learning and memory deficits, serving as a dementia animal model.

Purpose of the Study:

  • To investigate the therapeutic potential of compound 654-2 in improving cognitive deficits following brain injury.
  • To explore the underlying mechanisms of 654-2, including its effects on oxidative stress markers.

Main Methods:

  • Rats with induced brain injury and cognitive deficits received daily intraperitoneal injections of 654-2 (30 mg/kg) for 10 days.
  • Learning and memory were assessed using an avoidance response test.
  • Superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels in the forebrain were measured.

Related Experiment Videos

Main Results:

  • Compound 654-2 significantly improved learning and memory deficits in rats subjected to medial frontal cortex lesions or cerebral ischemia/reperfusion.
  • Treatment with 654-2 enhanced SOD activity, a key antioxidant enzyme.
  • 654-2 inhibited the elevation of MDA, a marker of lipid peroxidation and oxidative stress, in the forebrain.

Conclusions:

  • 654-2 demonstrates a neuroprotective effect by improving cognitive function after brain injury.
  • The compound likely exerts its beneficial effects through antioxidant mechanisms, protecting brain cells from free radical damage.